Security file · CUSIP G7709Q104
Royalty Pharma Plc
Royalty Pharma Plc · held by 3 tracked managers in Q3 2026.
Tracked holders · Q3 2026
3
+0 vs Q2 2026
Aggregate reported value
$374M
sum of holders' reported positions
New holders this quarter
0
0 added · 3 trimmed
Holder return since filing
—
weighted by each holder's position share · since filing
Ownership · Q3 2026
| Manager | Weight | Shares | Δ shares | Entry | Return | Value | Activity | |
|---|---|---|---|---|---|---|---|---|
| 1 | Samantha McLemore - Patient Capital Managementfiled 12 Nov ET | 6.35% | 3.42M | -4.9% | — | — | $200M | Trimmed |
| 2 | Pat Dorsey - Dorsey Asset Managementfiled 16 Nov ET | 8.23% | 2.42M | -1.7% | — | — | $141M | Trimmed |
| 3 | Torray Fundsfiled 29 Oct ET | 4.35% | 564K | -6.2% | — | — | $32.94M | Trimmed |
Holder count
Aggregate reported value
Quarterly aggregation
| Quarter | Holders | Δ holders | Aggregate value | Total shares |
|---|---|---|---|---|
| Q3 2026 | 3 | +0 | $374M | 6.40M |
| Q2 2026 | 3 | +1 | $373M | 6.66M |
| Q1 2026 | 2 | +1 | $140M | 2.92M |
| Q3 2025 | 1 | -2 | $110M | 3.12M |
| Q2 2025 | 3 | +1 | $226M | 6.27M |
| Q1 2025 | 2 | +0 | $421M | 13.54M |
| Q4 2024 | 2 | +1 | $329M | 12.89M |
| Q3 2024 | 1 | — | $342M | 12.09M |